Jens G. Lohr

1 Patent

• US125595592026

  Targeting Galectin-9 as a Therapeutic Strategy for T-cell Exhaustion in T-cell Acute Lymphoblastic Leukemia

  THE BRIGHAM AND WOMEN'S HOSPITAL, Inc.

  0 cites